The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition
Abstract
Background—Persistently high plasma endothelin-1 (ET-1) levels in diabetic patients have been associated with the development of cardiac fibrosis, which results from the deposition of extracellular matrix and fibroblast recruitment from an as-yet unknown source. The underlying mechanism, however, remains elusive. Here, we hypothesize that ET-1 might contribute to the accumulation of cardiac fibroblasts through an endothelial-to-mesenchymal transition in diabetic hearts. Methods and Results—We induced diabetes mellitus in vascular endothelial cell–specific ET-1 knockout [ET-1 f/f;Tie2-Cre (+)] mice and their wild-type littermates using the toxin streptozotocin. Gene expression and histological and functional parameters were examined at 8, 24, and 36 weeks after the induction of diabetes mellitus. Diabetes mellitus increased cardiac ET-1 expression in wild-type mice, leading to mitochondrial disruption and myofibril disarray through the generation of superoxide. Diabetic mice also showed impairment of cardiac microvascularization and a decrease in cardiac vascular endothelial growth factor expression. ET-1 further promotes cardiac fibrosis and heart failure through the accumulation of fibroblasts via endothelial-to-mesenchymal transition. All of these features were abolished in ET-1 f/f;Tie2-Cre (+) hearts. Targeted ET-1 gene silencing by small interfering RNA in cultured human endothelial cells ameliorated high glucose–induced phenotypic transition and acquisition of a fibroblast marker through the inhibition of transforming growth factor-β signaling activation and preservation of the endothelial cell-to-cell contact regulator VE-cadherin. Conclusions—These results provide new insights suggesting that diabetes mellitus–induced cardiac fibrosis is associated with the emergence of fibroblasts from endothelial cells and that this endothelial-to-mesenchymal transition process is stimulated by ET-1. Targeting endothelial cell–derived ET-1 might be beneficial in the prevention of diabetic cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Self-citationCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,654
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in Vivo
Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J.-I., Williams, S. C., Richardson, J. A., & Yanagisawa, M. (2001) · Developmental Biology · doi:10.1006/dbio.2000.0106 · Cited by 1,241
Self-citationIdentification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1
Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai, R., Oda, H., Kuwaki, T., Cao, W.-H., Kamada, N., et al. (1994) · Nature · doi:10.1038/368703a0 · Cited by 981
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050513 · Cited by 876
Heart Valve Development: Endothelial Cell Signaling and Differentiation
Armstrong, E. J., & Bischoff, J. (2004) · Circulation Research · doi:10.1161/01.res.0000141146.95728.da · Cited by 647
Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels
Abacı, A., Oğuzhan, A., Kahraman, S., Eryol, N. K., Ünal, S., Arınç, H., & Ergin, A. (1999) · Circulation · doi:10.1161/01.cir.99.17.2239 · Cited by 627
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options
Aneja, A., Tang, W. H. W., Bansilal, S., Garcia, M. J., & Farkouh, M. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.046 · Cited by 482
Chou, E., Suzuma, I., Way, K. J., Opland, D., Clermont, A. C., Naruse, K., Suzuma, K., Bowling, N. L., Vlahos, C. J., Aiello, L. P., et al. (2002) · Circulation · doi:10.1161/hc0302.102143 · Cited by 337
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
Park, J. Y., Takahara, N., Gabriele, A., Chou, E., Naruse, K., Suzuma, K., Yamauchi, T., Ha, S. W., Meier, M., Rhodes, C. J., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1239 · Cited by 278
Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus
Cardillo, C., Campia, U., Bryant, M. B., & Panza, J. A. (2002) · Circulation · doi:10.1161/01.cir.0000032260.01569.64 · Cited by 259
Collagen remodelling in myocardia of patients with diabetes.
Shimizu, M., Umeda, K., Sugihara, N., Yoshio, H., Ino, H., Takeda, R., Okada, Y., & Nakanishi, I. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.1.32 · Cited by 247
Way, K. J., Isshiki, K., Suzuma, K., Yokota, T., Zvagelsky, D., Schoen, F. J., Sandusky, G. E., Pechous, P. A., Vlahos, C. J., Wakasaki, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2709 · Cited by 180
Endothelin receptor antagonists in pulmonary arterial hypertension
Channick, R. N., Sitbon, O., Barst, R. J., Manes, A., & Rubin, L. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.042 · Cited by 174
Elevated plasma endothelin-1 levels in diabetes mellitus
Schneider, J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03060-1 · Cited by 164
Goumans, M.-J., van Zonneveld, A. J., & ten Dijke, P. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.01.001 · Cited by 159
Jain, R., Shaul, P. W., Borok, Z., & Willis, B. C. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0353oc · Cited by 151
Diabetes-induced Myocardial Structural Changes: Role of Endothelin-1 and its Receptors
Chen, S., Evans, T., Mukherjee, K., Karmazyn, M., & Chakrabarti, S. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1197 · Cited by 141
Nakajima, Y., Miyazono, K., Kato, M., Takase, M., Yamagishi, T., & Nakamura, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.193 · Cited by 122
Expression of Angiogenic Factors During Acute Coronary Syndromes in Human Type 2 Diabetes
Marfella, R., Esposito, K., Nappo, F., Siniscalchi, M., Sasso, F. C., Portoghese, M., Marino, M. P. D., Baldi, A., Cuzzocrea, S., Filippo, C. D., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2383 · Cited by 115
Rodríguez‐Pascual, F., Redondo‐Horcajo, M., & Lamas, S. (2003) · Circulation Research · doi:10.1161/01.res.0000078491.79697.7f · Cited by 97
Kakizawa, H., Itoh, M., Itoh, Y., Imamura, S., Ishiwata, Y., Matsumoto, T., Yamamoto, K., Kato, T., Ono, Y., Nagata, M., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.002 · Cited by 94
Anggrahini, D. W., Emoto, N., Nakayama, K., Widyantoro, B., Adiarto, S., Iwasa, N., Nonaka, H., Rikitake, Y., Kisanuki, Y. Y., Yanagisawa, M., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp026 · Cited by 94
Self-citationGustafsson, I., Kistorp, C., James, M. K., Faber, J. O., Dickstein, K., & Hildebrandt, P. R. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.057 · Cited by 64
Endothelin Receptor Antagonists in Cancer Therapy
Lalich, M., McNeel, D. G., Wilding, G., et al. (2007) · Cancer Investigation · doi:10.1080/07357900701522588 · Cited by 62
High Glucose Alters Cardiomyocyte Contacts and Inhibits Myofibrillar Formation
Dyntar, D., Sergeev, P., Klisic, J., Ambühl, P. M., SCHAUB, M. C., & Donath, M. Y. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1904 · Cited by 54
Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
Rosanò, L., Spinella, F., Castro, V. D., et al. (2006) · PubMed · Cited by 40
Gro�, M.-L., Hei, N.-H., Weckbach, M., et al. (2004) · Diabetologia · doi:10.1007/s00125-003-1309-z · Cited by 31
Wölkart, G., Pang, X., Stessel, H., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707325 · Cited by 17
Cited by
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Siti, H. N., Kamisah, Y., & Kamsiah, J. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.005 · Cited by 898
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Metadata
- Authors
- Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D. W., Adiarto, S., Iwasa, N., Yagi, K., Miyagawa, K., Rikitake, Y., Suzuki, T., Kisanuki, Y. Y., Yanagisawa, M., & Hirata, K.-I.
- Venue
- Circulation
- Published
- 2010-06-08
- Volume
- 121
- Issue
- 22
- Pages
- 2407-2418
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2031137884
- Cited by
- 385
- References
- 37
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.